Pharmaceutical Companies

Under the partnership, AstraZeneca and UNICEF will train and support 5,000 young people to take part in NCD prevention activities and youth-led health initiatives.

The Paonta Sahib site covers 14 acres and includes approximately 39,000 square metres of built-up manufacturing space.

Since its establishment, Sartorius Stedim Biotech has expanded the site through investments in infrastructure, production capacity, and employee training.

The Danish pharmaceutical company will receive exclusive rights to develop, manufacture and commercialise HRS-1596 outside mainland China, Hong Kong, Macau and Taiwan.

The deal comes as pharmaceutical companies increase investment in therapies that target RAS, a family of proteins involved in regulating cell growth and division.

The companies have also signed a non-binding MoU covering a broader global programme to evaluate ivonescimab in combination with additional AstraZeneca oncology therapies.

Merck plans to present the BRUNELLO results at the American Academy of Ophthalmology Annual Meeting in New Orleans on October 10 and discuss the findings with regulatory authorities.

The approval is based on Lilly’s QWINT Phase III clinical programme, which evaluated insulin efsitora alfa-gobe in more than 3,400 adults with T2D across four registration studies.

The agreement comes as Novo continues to strengthen its position in cardiometabolic medicines, where longer dosing intervals are a growing focus of research and development.

The approval gives AbbVie another Parkinson’s product following its acquisition of Cerevel Therapeutics.